Top Markets
Coin of the day
Parenteral Drugs (India) Ltd. Parenteral Drugs (India) Ltd.

Parenteral Drugs (India) Ltd.

PDPL
Rank in Stocks #38236
Parenteral Drugs (India) Limited operates as an India-based healthcare... Parenteral Drugs (India) Limited operates as an India-based healthcare enterprise, specializing in the production of a diverse range of pharmaceutical goods. Its offerings encompass various medicinal products, including intravenous and inhalation therapies, as well as veterinary infusions. The company's extensive product portfolio further comprises various intravenous (IV) solutions, such as those containing carbohydrates and electrolytes, diuretics, and solutions for dialysis and irrigation. Additionally, they provide anti-infective, anti-fungal, oncology, and anesthesia medications. The firm maintains a significant international presence, exporting its goods to numerous nations including Iraq, Yemen, Mozambique, Ghana, Kenya, Kyrgyzstan, Uzbekistan, Sudan, Vietnam, Cambodia, Liberia, Sri Lanka, Nepal, Myanmar, and Cameroon. Established in 1983, Parenteral Drugs (India) Limited's operations are headquartered in Indore, India.
Share Price
$0.03200404
Last synced: 2024-07-23
Market Cap
$1.12M
Change (1 day)
-8.12%
Change (1 year)
0.00%
Country
IN
Trade Parenteral Drugs (India) Ltd. (PDPL)

Category

P/S ratio for Parenteral Drugs (India) Ltd. (PDPL)
P/S ratio as of 2026 TTM: 0
According to Parenteral Drugs (India) Ltd. latest financial reports and stock price the company's current price-to-sales ratio (TTM) is 0. At the end of 2026 the company had a P/S ratio of 0.
P/S ratio history for Parenteral Drugs (India) Ltd. from 2026 to 2026
P/S ratio at the end of each year
Year P/S Ratio Change
Not enough data for the provided dates.
P/S ratio for similar companies or competitors